Consequently, like NPC1 deficiency, elevated AnxA6 levels reduced cholesterol-sensitive caveolae formation, FN secretion and integrin recycling [127,134,136], effectively reducing LDL-inducible migration and the invasion of CHO and A431 carcinoma cells [69,134,245]. This evidence concerns the gene ANXA6 and carcinoma.